Hereditary Breast & Ovarian Cancer
Germline
HR+/HER2−
TNBC risk
Stage II–III
BRCA1
BRCA2
PALB2
RAD51C
📈 Top pathway
Homologous recombination repair Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →
RAS/RAF Colorectal Cancer
Somatic
mCRC
BRAF V600E
MSS
KRAS
NRAS
BRAF
PIK3CA
📈 Top pathway
MAPK/ERK signaling Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →
NSCLC Precision Oncology
Somatic
Stage IIIB–IV
Adenocarcinoma
TKI-naive
EGFR
ALK
MET
ROS1
📈 Top pathway
EGFR-PI3K-mTOR axis Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →
Pan-Cancer Tumor Suppression
Somatic · LOF
Pan-cancer
TP53 hotspot
CDK4/6-driven
TP53
MDM2
CDKN2A
RB1
📈 Top pathway
p53 signaling / cell cycle arrest Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →
Glioblastoma Multiforme
IDH-wildtype
Primary GBM
MGMT methylated
WHO Grade 4
IDH1
IDH2
EGFR
PTEN
MGMT
📈 Top pathway
PI3K/AKT/mTOR Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →
Acute Myeloid Leukemia
FLT3-ITD+
De novo AML
Intermediate risk
ELN 2022
FLT3
NPM1
DNMT3A
IDH1
📈 Top pathway
FLT3 / epigenetic dysregulation Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →
Alzheimer's Disease
Late-onset
APOE ε4
Amyloid+/Tau+
MCI→AD
APP
APOE
PSEN1
PSEN2
TREM2
📈 Top pathway
Amyloid precursor processing Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →
Parkinson's Disease
LRRK2 G2019S
Sporadic PD
α-syn aggregation
Early-onset
SNCA
LRRK2
PARK7
PINK1
PRKN
📈 Top pathway
Mitochondrial quality control Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →
PI3K/AKT Pathway Cancers
PIK3CA H1047R
Breast · Endometrial
HR+ / HER2−
mTORC1-driven
PIK3CA
PTEN
AKT1
MTOR
📈 Top pathway
PI3K-AKT-mTOR signaling Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →
Type 2 Diabetes
GWAS-derived
T2D · non-obese
β-cell dysfunction
Insulin resistance
TCF7L2
PPARG
KCNJ11
SLC30A8
📈 Top pathway
Insulin secretion / glucose homeostasis Reactome/KEGG
⚖ Evidence strength
—
💊 Drug signals
—
Checking trials…
Explore Analysis →